IMCD Showcases Greener, Smarter, and Patient-Centric Pharmaceutical Innovations at CPHI Frankfurt 2025
a global leader in the distribution and formulation of specialty chemicals and ingredients, has announced its participation at CPHI Frankfurt 2025, taking place from 28–30 October. At this year’s event, IMCD will unveil an extensive portfolio of greener, smarter, and patient-centric solutions, underscoring its commitment to sustainable innovation and improved healthcare outcomes.
With an approach rooted in technical excellence, collaboration, and customer-centricity, IMCD aims to demonstrate how its capabilities are helping pharmaceutical companies worldwide accelerate development, enhance therapeutic efficacy, and advance patient well-being.
A Vision for a Smarter, Greener Pharmaceutical Future
As the global pharmaceutical landscape continues to evolve—driven by regulatory changes, sustainability imperatives, and patient expectations—IMCD stands at the forefront of enabling transformation. Its presence at CPHI Frankfurt reflects a broader strategic commitment: to help partners navigate complexity through science-driven innovation and cross-disciplinary collaboration.
Our presence at CPHI reflects our commitment to co-creating solutions that are not only innovative but also more sustainable and patient focused,” says Chhanda Kapadia, Group Director, Technical Services, IMCD Pharmaceuticals. “They are a first-class example of our globally connected network of technical laboratories. We are looking forward to showcasing these innovations and engaging with partners and customers to explore how we can shape the future of healthcare together.
Visitors to Booth 8.0S36 will have the opportunity to explore IMCD’s latest formulation concepts and technical insights, each illustrating how the company’s technical expertise, regulatory know-how, and global network translate into tangible solutions that address real-world pharmaceutical challenges.
The Three Pillars of Innovation: Greener, Smarter, and Patient-Centric
At the heart of IMCD’s exhibit are three key innovation pillars that define its pharmaceutical strategy and align with the most pressing needs of the industry.
1. Greener: Enabling Sustainable Pharmaceutical Manufacturing
IMCD’s “Greener” solutions demonstrate how sustainability can be integrated seamlessly into every stage of the pharmaceutical value chain, from the sourcing of eco-friendly excipients to the design of energy-efficient manufacturing processes.
These formulations highlight the company’s ability to balance environmental responsibility with performance excellence. By using renewable raw materials, reducing solvent use, and optimizing processing methods, IMCD enables pharmaceutical manufacturers to minimize environmental impact without compromising product quality or therapeutic outcomes.
This approach aligns with the growing emphasis on ESG-driven innovation in the pharmaceutical sector, helping partners meet regulatory requirements and achieve their sustainability goals.
2. Smarter: Harnessing Science and Technology to Solve Complex Challenges
The “Smarter” theme focuses on technical ingenuity and advanced formulation science. Leveraging its global network of technical centres, IMCD offers intelligent, data-driven solutions for complex formulation challenges, including solubility enhancement, modified release, and taste masking.
At CPHI Frankfurt 2025, visitors will discover cutting-edge prototypes that exemplify this expertise, such as dual-layer tablets, high-load capsules, and innovative coating systems. These technologies not only improve drug performance but also streamline manufacturing, reducing development timelines and production costs.
By integrating predictive modeling, formulation design, and global technical collaboration, IMCD delivers smart solutions that drive efficiency and innovation throughout the drug development lifecycle.
3. Patient-Centric: Putting Patients at the Heart of Innovation
The third pillar, “Patient-Centric,” reflects IMCD’s belief that true innovation begins with the end-user. The company’s formulation concepts are designed to enhance patient comfort, compliance, and experience, particularly in paediatric, geriatric, and chronic therapy applications.
IMCD’s experts will present dosage forms and delivery systems that are safer, more effective, and easier to administer—ranging from palatable liquid suspensions and orally dispersible tablets to advanced topical formulations. These solutions exemplify how patient needs can inspire functional design, improved bioavailability, and enhanced treatment adherence.
Six Innovative Formulation Concepts on Display
IMCD’s showcase will include six pioneering formulation concepts, each demonstrating how the company’s technical and regulatory expertise supports the rapid development of high-value therapies.
1. Apixaban Coated Tablet
A sustainable alternative to traditional roller compaction, this direct compression formulation minimizes manufacturing steps, reduces energy consumption, and simplifies cleaning processes. Despite its efficiency, it maintains comparable performance to the originator product, making it both eco-friendly and cost-effective.
2. Apremilast Ointment
Developed for topical psoriasis treatment, this innovative ointment enhances API solubility and skin permeation, providing a non-greasy, easy-to-apply formulation. It offers patients a convenient and tolerable alternative to oral therapy, avoiding systemic side effects while maintaining efficacy.
3. Caffeine SR Effervescent Tablet
An inventive dual-release system that combines immediate and sustained caffeine delivery, providing long-lasting energy without the typical “crash.” The effervescent format promotes hydration and compliance, while taste-masking technology ensures a pleasant experience for consumers.
4. Ginkgo Coated Tablet
A once-daily, direct-compression liposomal tablet containing Ginkgo biloba extract. This formulation enhances absorption and stability while delivering improved bioavailability in a compact, easy-to-swallow form—ideal for nutraceutical and cognitive support applications.
5. Terbinafine Film-Forming Solution
This transparent, water-resistant film provides prolonged antifungal action and a pleasant, non-tacky finish, offering patients an advanced, comfortable approach to treating athlete’s foot and similar conditions. The formulation demonstrates how innovative film technology can improve therapeutic efficacy and user experience.
6. Mucoadhesive Gel Platform
A versatile, multi-application platform designed for targeted mucosal drug delivery across oral, buccal, vaginal, and other routes. The gel enhances residence time, ensuring longer drug contact and improved absorption, while offering new possibilities for product differentiation and patient comfort.
Each of these formulations showcases IMCD’s ability to combine regulatory insight, material expertise, and formulation excellence to help customers move quickly from concept to market-ready product
A Global Network of Innovation and Collaboration
IMCD’s presence at CPHI Frankfurt reflects the company’s unique position as a trusted global partner in the pharmaceutical value chain. With more than 65 laboratories and technical centres worldwide, IMCD leverages local expertise supported by global collaboration to accelerate innovation and ensure compliance with regional regulatory standards.
Through this network, IMCD supports customers in all aspects of formulation development, from excipient selection and process optimization to product stability and scalability. Its technical experts work hand-in-hand with customers, providing tailor-made solutions that address the complex challenges of modern drug development.
Building a Sustainable Future for Pharma
In line with its corporate sustainability commitments, IMCD continues to invest in greener technologies, renewable ingredients, and circular economy principles. The company’s efforts extend beyond product innovation to include sustainable supply chain management, ethical sourcing, and reducing its carbon footprint through responsible operations.
By promoting formulations that optimize efficiency, minimize waste, and extend product lifespans, IMCD helps its partners meet global sustainability targets and prepare for a more resilient, low-impact pharmaceutical future.
Join IMCD at CPHI Frankfurt 2025
IMCD invites all attendees to visit Booth 8.0S36 to meet its technical experts, explore its latest innovations, and discuss how tailored, sustainable solutions can help bring better, safer medicines to market.
